Vitiligo history and symptoms: Difference between revisions
Joao Silva (talk | contribs) |
Joao Silva (talk | contribs) No edit summary |
||
| Line 5: | Line 5: | ||
==Overview== | ==Overview== | ||
[[Vitiligo]] constitutes one of the most frequent [[pigment]] disorders, affecting about 1% of the world's population, with no preference of [[race]], age, [[gender]], or country. It commonly starts to manifest around the second decade of life, with a gradual progress of [[depigmentation]], mostly due to loss of [[melanocytes]].<ref>{{cite book | last = Soutor | first = Carol | title = Clinical dermatology | publisher = McGraw-Hill Education/Lange Medical Books | location = New York | year = 2013 | isbn = 978-0-07-177296-9 }}</ref><ref name="TaïebPicardo2007">{{cite journal|last1=Taïeb|first1=Alain|last2=Picardo|first2=Mauro|title=The definition and assessment of vitiligo: a consensus report of the Vitiligo European Task Force|journal=Pigment Cell Research|volume=20|issue=1|year=2007|pages=27–35|issn=0893-5785|doi=10.1111/j.1600-0749.2006.00355.x}}</ref> | [[Vitiligo]] constitutes one of the most frequent [[pigment]] disorders, affecting about 1% of the world's population, with no preference of [[race]], [[age]], [[gender]], or country. It commonly starts to manifest around the second decade of life, with a gradual progress of [[depigmentation]], mostly due to loss of [[melanocytes]].<ref>{{cite book | last = Soutor | first = Carol | title = Clinical dermatology | publisher = McGraw-Hill Education/Lange Medical Books | location = New York | year = 2013 | isbn = 978-0-07-177296-9 }}</ref><ref name="TaïebPicardo2007">{{cite journal|last1=Taïeb|first1=Alain|last2=Picardo|first2=Mauro|title=The definition and assessment of vitiligo: a consensus report of the Vitiligo European Task Force|journal=Pigment Cell Research|volume=20|issue=1|year=2007|pages=27–35|issn=0893-5785|doi=10.1111/j.1600-0749.2006.00355.x}}</ref> | ||
==History== | ==History== | ||
For patients presenting for the first time with patches of [[skin]] [[depigmentation]], a thorough history and [[physical examination]] should be performed, including examination under the ''Wood's lamp'' in order to rule out other potentially life-threatening disorders. The initial onset of the condition may be abrupt, however, afterwards it usually progresses slowly, with expansion of [[skin]] [[depigmentation]] with no concomitant [[symptoms]].<ref name="TaïebPicardo2009">{{cite journal|last1=Taïeb|first1=Alain|last2=Picardo|first2=Mauro|title=Vitiligo|journal=New England Journal of Medicine|volume=360|issue=2|year=2009|pages=160–169|issn=0028-4793|doi=10.1056/NEJMcp0804388}}</ref><ref>{{cite book | last = Soutor | first = Carol | title = Clinical dermatology | publisher = McGraw-Hill Education/Lange Medical Books | location = New York | year = 2013 | isbn = 978-0-07-177296-9 }}</ref> | [[Vitiligo]] is one of the most common diseases of [[depigmentation]]. It affects 0.5% to 1% of the world population, without preference for a particular [[race]], [[gender]], [[age]] or country. For patients presenting for the first time with patches of [[skin]] [[depigmentation]], a thorough history and [[physical examination]] should be performed, including examination under the ''Wood's lamp'' in order to rule out other potentially life-threatening disorders. The initial onset of the condition may be abrupt, however, afterwards it usually progresses slowly, with expansion of [[skin]] [[depigmentation]] with no concomitant [[symptoms]].<ref name="TaïebPicardo2009">{{cite journal|last1=Taïeb|first1=Alain|last2=Picardo|first2=Mauro|title=Vitiligo|journal=New England Journal of Medicine|volume=360|issue=2|year=2009|pages=160–169|issn=0028-4793|doi=10.1056/NEJMcp0804388}}</ref><ref>{{cite book | last = Soutor | first = Carol | title = Clinical dermatology | publisher = McGraw-Hill Education/Lange Medical Books | location = New York | year = 2013 | isbn = 978-0-07-177296-9 }}</ref> | ||
==Common Symptoms== | ==Common Symptoms== | ||
Revision as of 17:39, 25 June 2014
|
Vitiligo Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
|
Vitiligo history and symptoms On the Web |
|
American Roentgen Ray Society Images of Vitiligo history and symptoms |
|
Risk calculators and risk factors for Vitiligo history and symptoms |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: João André Alves Silva, M.D. [2]
Overview
Vitiligo constitutes one of the most frequent pigment disorders, affecting about 1% of the world's population, with no preference of race, age, gender, or country. It commonly starts to manifest around the second decade of life, with a gradual progress of depigmentation, mostly due to loss of melanocytes.[1][2]
History
Vitiligo is one of the most common diseases of depigmentation. It affects 0.5% to 1% of the world population, without preference for a particular race, gender, age or country. For patients presenting for the first time with patches of skin depigmentation, a thorough history and physical examination should be performed, including examination under the Wood's lamp in order to rule out other potentially life-threatening disorders. The initial onset of the condition may be abrupt, however, afterwards it usually progresses slowly, with expansion of skin depigmentation with no concomitant symptoms.[3][4]
Common Symptoms
Less Common Symptoms
References
- ↑ Soutor, Carol (2013). Clinical dermatology. New York: McGraw-Hill Education/Lange Medical Books. ISBN 978-0-07-177296-9.
- ↑ Taïeb, Alain; Picardo, Mauro (2007). "The definition and assessment of vitiligo: a consensus report of the Vitiligo European Task Force". Pigment Cell Research. 20 (1): 27–35. doi:10.1111/j.1600-0749.2006.00355.x. ISSN 0893-5785.
- ↑ Taïeb, Alain; Picardo, Mauro (2009). "Vitiligo". New England Journal of Medicine. 360 (2): 160–169. doi:10.1056/NEJMcp0804388. ISSN 0028-4793.
- ↑ Soutor, Carol (2013). Clinical dermatology. New York: McGraw-Hill Education/Lange Medical Books. ISBN 978-0-07-177296-9.